Schedule 13G ownership disclosure
PASSAGE BIO INC
Security class unavailable · CUSIP: 702712100
Event date: 2024-03-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,845,871
- Percent of class
- 8.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-002687
- Form type
- SC 13G
- Filer
- Lynx1 Capital Management LP
- CIK
- CIK 1910456
- Filed
- Mar 29, 2024
- Reporting period
- Mar 19, 2024
- Description
- Schedule 13G beneficial ownership